FI950302A0 - Menetelmä kreatiinivaraston lisäämiseksi - Google Patents

Menetelmä kreatiinivaraston lisäämiseksi

Info

Publication number
FI950302A0
FI950302A0 FI950302A FI950302A FI950302A0 FI 950302 A0 FI950302 A0 FI 950302A0 FI 950302 A FI950302 A FI 950302A FI 950302 A FI950302 A FI 950302A FI 950302 A0 FI950302 A0 FI 950302A0
Authority
FI
Finland
Prior art keywords
procedure
increasing creatine
supply
creatine supply
increasing
Prior art date
Application number
FI950302A
Other languages
English (en)
Swedish (sv)
Other versions
FI950302A (fi
Inventor
Eric Hultman
Roger Harris
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI950302(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI950302A0 publication Critical patent/FI950302A0/fi
Publication of FI950302A publication Critical patent/FI950302A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI950302A 1992-07-24 1995-01-24 Menetelmä kreatiinivaraston lisäämiseksi FI950302A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215746A GB9215746D0 (en) 1992-07-24 1992-07-24 A method of increasing creatine supply depot
PCT/SE1993/000631 WO1994002127A1 (en) 1992-07-24 1993-07-15 A method of increasing creatine supply depot

Publications (2)

Publication Number Publication Date
FI950302A0 true FI950302A0 (fi) 1995-01-24
FI950302A FI950302A (fi) 1995-01-24

Family

ID=10719231

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950302A FI950302A (fi) 1992-07-24 1995-01-24 Menetelmä kreatiinivaraston lisäämiseksi

Country Status (9)

Country Link
US (1) US5767159A (fi)
EP (1) EP0652748A1 (fi)
JP (1) JPH07509230A (fi)
AU (1) AU678559B2 (fi)
CA (1) CA2140768C (fi)
FI (1) FI950302A (fi)
GB (1) GB9215746D0 (fi)
NZ (1) NZ254307A (fi)
WO (1) WO1994002127A1 (fi)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
IT1271687B (it) * 1994-08-04 1997-06-04 Flamma Spa Sali organici idrosolubili della creatina
GB9517443D0 (en) * 1994-12-17 1995-10-25 Univ Nottingham Increasing creatine and glycogen concentration in muscle
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6274161B1 (en) * 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US8128955B2 (en) * 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
WO1998000148A1 (de) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink
GB9616910D0 (en) * 1996-08-12 1996-09-25 Dunnett Mark A method of increasing ›-alanylihistidine pipetide synthesis and accumulation in humans and animals
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
IT1298420B1 (it) * 1996-11-19 2000-01-05 Monsanto It Spa Uso della creatina nell'insufficienza cardio-respiratoria
DE19653225A1 (de) * 1996-12-20 1998-06-25 Sueddeutsche Kalkstickstoff Kreatin-pyruvate und Verfahren zu deren Herstellung
NZ332830A (en) * 1996-12-20 2000-04-28 Sueddeutsche Kalkstickstoff Creatine pyruvates, method for their production and their use in medicaments for weight control, body fat control, increasing muscle strength, the treatment of oxygen deficiency conditions and as free radical scavengers
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
WO1999021565A1 (en) 1997-10-24 1999-05-06 Cornell Research Foundation, Inc. Nutritional supplement for cerebral metabolic insufficiencies
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
ES2288990T3 (es) * 2000-09-14 2008-02-01 Board Of Regents Of The University Of Nebraska Compuestos y formulaciones pronutrientes de ester de creatinina.
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
AU2003247224A1 (en) * 2002-06-19 2004-01-06 N.V. Nutricia Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
GB0518579D0 (en) * 2005-09-12 2005-10-19 Cr Technologies Llp Controlled delivery creatine formulations and method of using the same
CN106038473A (zh) 2005-05-23 2016-10-26 自然选择国际公司 持续释放β‑丙氨酸的组合物和方法
US7858599B2 (en) * 2005-12-30 2010-12-28 Hander Robert W Enhancement of urogenital function
JP2009527504A (ja) * 2006-02-23 2009-07-30 イオメディックス スリープ インターナショナル エスアールエル 良質な睡眠の誘導および維持のための組成物および方法
EP2027782A1 (en) * 2007-08-15 2009-02-25 Nestec S.A. Increasing the efficiency of utilization of ingested creatine
EP2098124A1 (en) 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate gel
US8350077B2 (en) 2008-12-24 2013-01-08 Vertex Closed Joint Stock Company Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
EP3368498A4 (en) 2015-10-27 2019-06-12 Cytozyme Animal Nutrition, Inc. ANIMAL NUTRITIONAL COMPOSITIONS AND RELATED METHODS
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
US10821123B2 (en) 2016-02-01 2020-11-03 Bioenergy Life Science, Inc. Use of ribose for treatment of subjects having congestive heart failure
US11246846B2 (en) 2017-10-23 2022-02-15 Michael S. Tempesta Trisodium citrate compositions having enhanced uptake across digestive mucosa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (fi) * 1973-06-27 1977-07-01 Biotherax Lab
IT1214598B (it) * 1985-04-17 1990-01-18 Schiapparelli Farma Uso terapeutico della fosfocreatina.
IT1191639B (it) * 1985-11-11 1988-03-23 Schiapparelli Farma Composizione farmaceutica contenente fosfocreatina e metodo per preparla
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
US5308627A (en) * 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
US5091404A (en) * 1990-10-05 1992-02-25 Elgebaly Salwa A Method for restoring functionality in muscle tissue
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink

Also Published As

Publication number Publication date
NZ254307A (en) 1996-12-20
AU678559B2 (en) 1997-06-05
WO1994002127A1 (en) 1994-02-03
EP0652748A1 (en) 1995-05-17
JPH07509230A (ja) 1995-10-12
US5767159A (en) 1998-06-16
CA2140768C (en) 1999-12-07
GB9215746D0 (en) 1992-09-09
AU4594893A (en) 1994-02-14
FI950302A (fi) 1995-01-24
CA2140768A1 (en) 1994-02-03

Similar Documents

Publication Publication Date Title
FI950302A0 (fi) Menetelmä kreatiinivaraston lisäämiseksi
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
FI925526A0 (fi) Kontrastmedel foer ultraljudsavbildning
FI942166A0 (fi) Menetelmiä restenoosin ehkäisemiseksi
DE69324782T2 (de) Versorgungsschaltung
DE69308230T2 (de) Fördersystem
DE69314651D1 (de) Transportsystem
NO955230D0 (no) Strömforsyningssystem
NO924675D0 (no) Gassloeft-enhet for kveilroer
DE69219902T2 (de) Gleichstrom-Wechselstrom Versorgung
FI940047A0 (fi) Syöttöpumppu
FI943660A (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
IT8819422A0 (it) Rullo per tinteggiare.
FI945420A0 (fi) Laite puolan vaihtamiseksi
NO923137D0 (no) Forstasjon
ITVI920102A0 (it) Levigatrice-lucidatrice per superfici cilindriche
FI98341B (fi) Menetelmä poikittaisleikkeiden paikallistamiseksi
NO950250D0 (no) Fremgangsmåte for ökning av kreatinforsyningsdepot
KR940002485U (ko) 혁대용 연결편
FI934435A0 (fi) Sikojen ruokintamenetelmä
KR930019087U (ko) 집어등용 안정기
DE9209511U1 (de) Futtermittel
KR940003393U (ko) 이송용 롤러 컨베이어(Roller Conveyor)
SE9102303D0 (sv) Haallare foer takraecke
KR940022528U (ko) 용액 공급용 용기

Legal Events

Date Code Title Description
FD Application lapsed